RAXOSPEC Trademark

Trademark Overview

On Wednesday, November 18, 2020, a trademark application was filed for RAXOSPEC with the United States Patent and Trademark Office. The USPTO has given the RAXOSPEC trademark a serial number of 90328448. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 28, 2022. This trademark is owned by Sumitomo Dainippon Pharma Oncology, Inc.. The RAXOSPEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
raxospec

General Information

Serial Number90328448
Word MarkRAXOSPEC
Filing DateWednesday, November 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSumitomo Dainippon Pharma Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameSumitomo Dainippon Pharma Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, February 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 29, 2021ASSIGNED TO EXAMINER
Tuesday, March 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 21, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

raxospec cancer treatment preparations pharmaceutical